Valuation: Ion Beam Applications, SA

Market Cap 449M 504M 419M 381M 716M 48.76B 723M 5.02B 1.97B 24.84B 1.89B 1.85B 79.6B P/E 2026 *
19.1x
P/E 2027 * 13.9x
Enterprise Value 496M 556M 462M 420M 791M 53.84B 799M 5.55B 2.17B 27.43B 2.09B 2.04B 87.89B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.7x
Free-Float
60.41%
Yield 2026 *
1.94%
Yield 2027 * 2.2%
1 day-6.25%
1 week-5.20%
Current month-5.20%
1 month-5.79%
3 months-10.52%
6 months+12.50%
Current year+10.60%
1 week 16.88
Extreme 16.875
18
1 month 16.88
Extreme 16.875
18.5
Current year 15
Extreme 15
20.1
1 year 11.45
Extreme 11.45
20.1
3 years 8.65
Extreme 8.65
20.1
5 years 8.65
Extreme 8.65
20.95
10 years 6.34
Extreme 6.34
61.6
Manager TitleAgeSince
Chief Executive Officer 58 2012-04-30
Chief Tech/Sci/R&D Officer 78 1986-03-27
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 65 2013-04-30
Director/Board Member 78 1991-04-30
Director/Board Member 58 2012-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-6.25%-5.20% - - 508M
-1.52%-3.42%+20.92%+30.78% 245B
-0.47%-1.85%+4.16%+0.11% 154B
+0.21%+2.16%-5.79%+40.49% 146B
+1.11%-3.69%-56.16%-19.34% 60.26B
-1.80%-2.41%+9.80%+14.30% 49.44B
-0.54%-2.40%+21.37%+52.00% 47.67B
-0.78%+0.76%-21.16%-19.35% 48.04B
+0.83%-0.21%-6.98%+35.90% 45.74B
-1.57%-2.34%+34.80%+60.48% 42.84B
Average -1.38%-1.73%+0.11%+21.71% 93.2B
Weighted average by Cap. -0.98%-2.10%+3.80%+22.42%

Financials

2026 *2027 *
Net sales 633M 710M 591M 537M 1.01B 68.77B 1.02B 7.08B 2.77B 35.04B 2.67B 2.61B 112B 643M 720M 599M 545M 1.02B 69.76B 1.04B 7.19B 2.81B 35.55B 2.7B 2.65B 114B
Net income 22.82M 25.59M 21.28M 19.34M 36.4M 2.48B 36.76M 255M 99.86M 1.26B 96.04M 93.97M 4.04B 32.74M 36.71M 30.53M 27.75M 52.22M 3.55B 52.74M 366M 143M 1.81B 138M 135M 5.8B
Net Debt 46.78M 52.45M 43.62M 39.65M 74.61M 5.08B 75.36M 523M 205M 2.59B 197M 193M 8.29B 3.88M 4.35M 3.61M 3.29M 6.18M 421M 6.24M 43.36M 16.96M 214M 16.31M 15.96M 687M
Projected Income Statement - Annual - Ion Beam Applications, SA
Logo Ion Beam Applications, SA
Ion Beam Applications, SA (IBA) is gespecialiseerd in het ontwerp, de vervaardiging en de verkoop van apparatuur voor de diagnose en de behandeling van kanker. De omzet (voor binnen de groep afgestoten activiteiten) per productfamilie wordt als volgt onderverdeeld: - apparatuur en systemen voor diagnose en therapeutische behandeling (89,4%): apparatuur voor protontherapie (59,8% van de omzet; wereldwijd n° 1), deeltjesversnellers (40,2%) gebruikt voor de productie van radio-isotopen (cyclotrons) en voor de ontwikkeling van sterilisatie- en ionisatieoplossingen (Rhodotron®); - dosimetrie-apparatuur en -oplossingen (10,6%; wereldwijd nr. 1): meet- en analyse-instrumenten voor de doses van straling en radiotherapie en medische beeldvorming. De geografische verdeling van de omzet is als volgt: België (2,3%), Verenigde Staten (34%), China (11,6%), Duitsland (6,5%), India (5,8%) en andere (39,8%).
Employees
2,264
Date Price Change Volume
26-10-08 US$16.88 -6.25% 100
26-10-02 US$18.00 +1.12% 200
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Ion Beam Applications, SA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
15.44EUR
Average target price
17.62EUR
Spread / Average Target
+14.15%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Ion Beam Applications, SA